BMPR1A — Bone Morphogenetic Protein Receptor Type 1A

Migration, Crosslink

📖

BMPR1A — Bone Morphogenetic Protein Receptor Type 1A

active

wiki page Created: 2026-04-02T07:19:22 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-bmpr1a

📖 Wiki Page

gene2382 wordssynced 2026-04-02

BMPR1A — Bone Morphogenetic Protein Receptor Type 1A

<div class="infobox infobox-gene">
<div class="infobox-header">BMPR1A</div>
<div class="infobox-row"><strong>Full Name:</strong> Bone Morphogenetic Protein Receptor Type 1A</div>
<div class="infobox-row"><strong>Chromosomal Location:</strong> 10q22.3</div>
<div class="infobox-row"><strong>NCBI Gene ID:</strong> NCBI Gene 595</div>
<div class="infobox-row"><strong>OMIM:</strong> 604798</div>
<div class="infobox-row"><strong>Ensembl ID:</strong> ENSG00000107779</div>
<div class="infobox-row"><strong>UniProt ID:</strong> O00238</div>
<div class="infobox-row"><strong>Associated Diseases:</strong> Juvenile polyposis syndrome, Pulmonary arterial hypertension, Fibrodysplasia ossificans progressiva, Alzheimer's disease, Parkinson's disease</div>
</div>

Overview

BMPR1A (Bone Morphogenetic Protein Receptor Type 1A), also known as ALK3 (Activin receptor-Like Kinase 3), is a transmembrane serine/threonine kinase receptor that plays critical roles in embryonic development, skeletal formation, tissue homeostasis, and central nervous system function [1]. BMPR1A is a key component of the [BMP signaling pathway](/mechanisms/bmp-signaling-pathway) and mediates signaling for multiple BMP ligands including BMP2, BMP4, BMP6, and BMP7.

...

BMPR1A — Bone Morphogenetic Protein Receptor Type 1A

<div class="infobox infobox-gene">
<div class="infobox-header">BMPR1A</div>
<div class="infobox-row"><strong>Full Name:</strong> Bone Morphogenetic Protein Receptor Type 1A</div>
<div class="infobox-row"><strong>Chromosomal Location:</strong> 10q22.3</div>
<div class="infobox-row"><strong>NCBI Gene ID:</strong> NCBI Gene 595</div>
<div class="infobox-row"><strong>OMIM:</strong> 604798</div>
<div class="infobox-row"><strong>Ensembl ID:</strong> ENSG00000107779</div>
<div class="infobox-row"><strong>UniProt ID:</strong> O00238</div>
<div class="infobox-row"><strong>Associated Diseases:</strong> Juvenile polyposis syndrome, Pulmonary arterial hypertension, Fibrodysplasia ossificans progressiva, Alzheimer's disease, Parkinson's disease</div>
</div>

Overview

BMPR1A (Bone Morphogenetic Protein Receptor Type 1A), also known as ALK3 (Activin receptor-Like Kinase 3), is a transmembrane serine/threonine kinase receptor that plays critical roles in embryonic development, skeletal formation, tissue homeostasis, and central nervous system function [1]. BMPR1A is a key component of the [BMP signaling pathway](/mechanisms/bmp-signaling-pathway) and mediates signaling for multiple BMP ligands including BMP2, BMP4, BMP6, and BMP7.

In the nervous system, BMPR1A regulates neural stem cell proliferation and differentiation, dopaminergic neuron development, synaptic plasticity, and neuroprotection. Dysregulated BMP signaling through BMPR1A has been implicated in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), amyotrophic lateral sclerosis (ALS), and other neurodegenerative conditions [2][3].

The gene is located on chromosome 10q22.3, encodes a 532-amino acid protein with a molecular weight of approximately 60 kDa, and is widely expressed throughout the brain with particularly high levels in the [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), basal ganglia, and cerebellum.

Function

Receptor Structure and Signaling

BMPR1A is a type I serine/threonine kinase receptor consisting of:

Extracellular domain: Ligand-binding region with cysteine-rich motifs
Transmembrane domain: Single-pass membrane anchor
Cytoplasmic serine/threonine kinase domain: Intrinsic kinase activity for signal transduction

BMPR1A functions as the primary BMP type I receptor, binding BMP ligands with high affinity. Upon ligand binding, BMPR1A forms a heteromeric complex with type II receptors (BMPR2, ACVR2A, ACVR2B) [1]. The type II receptor phosphorylates the GS domain (glycine-serine rich domain) of BMPR1A, activating its kinase domain. Activated BMPR1A then phosphorylates downstream SMAD effectors.

SMAD-Dependent Signaling

The canonical BMPR1A signaling pathway involves:

SMAD1/5/8 phosphorylation: Activated BMPR1A phosphorylates receptor-regulated SMADs (R-SMADs)

SMAD complex formation: Phosphorylated SMAD1/5/8 forms complexes with SMAD4 (co-SMAD)

Nuclear translocation: The SMAD complex translocates to the nucleus

Gene transcription regulation: SMAD complexes bind DNA and regulate transcription of target genes

This pathway controls:

Neural stem cell fate decisions
Neuronal differentiation
Axon guidance
Dendrite morphogenesis
Synapse formation and plasticity

Non-Canonical Signaling

BMPR1A also signals through non-SMAD pathways:

MAPK pathways: Activation of ERK, JNK, and p38 MAPK
PI3K/AKT pathway: Pro-survival signaling
Rho GTPase pathways: Cytoskeletal regulation
Wnt cross-talk: Interaction with canonical Wnt/β-catenin signaling

Neural Stem Cell Regulation

BMPR1A plays a critical role in neural stem cell (NSC) biology [4]:

Proliferation: BMP signaling promotes NSC proliferation in the subventricular zone and hippocampus

Differentiation: BMPR1A-mediated signaling influences neuronal versus glial fate decisions

Maintenance: Continuous BMP signaling maintains NSC pools

Neurogenesis: Regulates the generation of new neurons in adult brain

Synaptic Function

In mature neurons, BMPR1A regulates:

Synapse formation: Dendritic spine development and presynaptic differentiation
Synaptic plasticity: Long-term potentiation (LTP) and depression (LTD)
Neurotransmitter regulation: Modulation of GABAergic and glutamatergic signaling
Axon guidance: Pathfinding during development and regeneration

Expression Pattern

Brain Regional Distribution

BMPR1A exhibits a widespread expression pattern throughout the brain:

Cerebral cortex: High expression in layers II-VI, particularly in pyramidal neurons
Hippocampus: Strong expression in CA1-CA3 regions and dentate gyrus granule cells
Basal ganglia: High levels in striatum and substantia nigra
Cerebellum: Purkinje cells and granule cells
Thalamus and hypothalamus: Moderate expression
Brainstem: Motor nuclei and sensory relay regions

Cellular Expression

Within the brain, BMPR1A is expressed in:

Neurons: Both excitatory and inhibitory neurons
Astrocytes: Astrocytic BMPR1A regulates neuroinflammation
Oligodendrocytes: Myelinating oligodendrocyte precursors
Neural stem cells: Ventricular zone and subventricular zone
Microglia: Modulates microglial activation states

Developmentally Regulated Expression

BMPR1A expression is dynamically regulated:

High during embryonic neurogenesis
Maintained in adult neurogenic niches
Altered in aging and disease states

Disease Associations

Alzheimer's Disease

BMPR1A dysfunction is implicated in [Alzheimer's disease](/diseases/alzheimers-disease) through multiple mechanisms [2]:

Amyloid-beta toxicity: Altered BMP signaling affects neuronal sensitivity to [amyloid-beta](/proteins/amyloid-beta) toxicity

Tau pathology: BMP-SMAD signaling interacts with tau phosphorylation pathways

Neuroinflammation: BMPR1A in astrocytes regulates inflammatory responses [5]

Synaptic dysfunction: Impaired synaptic plasticity and memory formation

Neurogenesis impairment: Reduced hippocampal neurogenesis in AD

The interplay between BMP signaling and amyloid pathology involves:

BMP2/4 expression is altered in AD brains
SMAD signaling is dysregulated
Inflammatory cytokines modulate BMPR1A expression

Parkinson's Disease

In [Parkinson's disease](/diseases/parkinsons-disease), BMPR1A plays both protective and pathogenic roles [3]:

Dopaminergic neuron survival: BMP signaling promotes dopaminergic neuron survival

Neuroinflammation: Astrocytic BMPR1A modulates microglia-mediated inflammation

Alpha-synuclein interaction: BMP signaling may influence [alpha-synuclein](/proteins/alpha-synuclein) aggregation

Therapeutic potential: BMP receptor activation may provide neuroprotection

Amyotrophic Lateral Sclerosis (ALS)

BMPR1A signaling is dysregulated in ALS [6]:

Altered BMP signaling in motor neurons
Glial cell contributions to disease progression
Potential therapeutic target for motor neuron protection

Cancer

While not directly neurodegenerative, BMPR1A is also associated with:

Juvenile polyposis syndrome (gastrointestinal polyps)
Pulmonary arterial hypertension
Fibrodysplasia ossificans progressiva
Various cancers (altered BMP signaling in tumor progression)

Molecular Mechanisms in Neurodegeneration

Amyloid-Beta Interactions

In Alzheimer's disease, BMPR1A signaling interacts with amyloid pathology through:

Receptor regulation: Amyloid-beta downregulates BMPR1A expression

Signal transduction: Impairs downstream SMAD signaling

Synaptic dysfunction: Disrupts BMP-mediated synaptic plasticity

Inflammatory amplification: Synergistic effects with neuroinflammation

Tau Phosphorylation

BMPR1A-SMAD signaling influences tau pathology:

SMAD proteins can interact with tau kinases
BMP signaling modulates tau phosphorylation status
Therapeutic modulation of BMP signaling may reduce tau pathology

Neuroinflammation

BMPR1A in glial cells regulates neuroinflammation [5]:

Astrocytic BMPR1A: Anti-inflammatory effects in some contexts
Microglial activation: BMP signaling modulates microglial phenotypes
Cytokine cross-talk: Inflammatory cytokines alter BMPR1A expression

Neurogenesis and Repair

BMPR1A signaling is crucial for:

Adult hippocampal neurogenesis (memory function)
Subventricular zone neurogenesis (olfactory function)
Neuronal replacement potential (therapeutic applications)

Therapeutic Implications

Small Molecule Modulators

BMP receptor agonists: Synthetic BMP analogs for neuroprotection

Kinase inhibitors: Selective BMPR1A inhibitors (for pathological signaling)

SMAD pathway modulators: Downstream pathway targets

Biological Approaches

BMP protein therapy: Direct BMP delivery to affected brain regions

Gene therapy: AAV-mediated BMPR1A expression or modulation

Cell therapy: Stem cells engineered to express BMP ligands

Target Validation

BMPR1A represents a compelling therapeutic target because:

Genetic evidence: GWAS hits in BMPR1A region for PD and AD
Mechanistic rationale: Clear role in neuronal survival and neuroinflammation
Accessibility: Can be targeted with biologics or small molecules
Druggability: Multiple therapeutic modalities available

Biomarkers

BMPR1A-related biomarkers could include:

CSF BMP ligand levels[@bmpr1a_csf]
BMPR1A expression in blood cells
SMAD phosphorylation status
Exosomal BMP signaling molecules

Clinical Evidence

Alzheimer's Disease Studies

Clinical evidence for BMPR1A involvement in AD includes:

Post-mortem brain studies: Altered BMPR1A expression and signaling in AD hippocampus[@bmpr1a_ad2021]

Genetic studies: BMPR1A polymorphisms associated with AD risk in genome-wide studies

Biomarker studies: Elevated BMP ligands in AD CSF[@bmpr1a_csf]

iPSC studies: BMP signaling dysregulation in AD patient-derived neurons[@bmpr1a_iPSC]

Parkinson's Disease Studies

In Parkinson's disease:

Genetic association: BMPR1A variants linked to PD susceptibility[@bmpr1a_pd2022]

Post-mortem studies: Altered BMP receptor expression in substantia nigra

Neuroimaging: BMP-related markers correlate with disease progression

Therapeutic trials: BMP agonists in clinical trials for PD

Amyotrophic Lateral Sclerosis

ALS research reveals:

Dysregulated BMP signaling in motor neuron disease[@samantaray2015]
Glial contribution to altered BMP signaling
Potential therapeutic target

Biomarker Development

BMPR1A offers biomarker potential:

Blood-based BMPR1A measurements
SMAD phosphorylation as activity marker
CSF BMP ligand profiling
Imaging-based approaches

Animal Models

Transgenic Mouse Models

BMPR1A conditional knockout mice: Cell-type-specific deletion

Neural stem cell-specific knockout: Neurogenesis impairment
Neuron-specific knockout: Synaptic dysfunction
Astrocyte-specific knockout: Neuroinflammation alterations

BMPR1A overexpression transgenic mice: Gain-of-function models

Enhanced BMP signaling
Altered neuronal survival

Humanized BMPR1A knock-in mice: Engineered for drug testing

Rodent Models of Neurodegeneration

MPTP model of PD: BMP signaling alterations
6-OHDA model: BMPR1A changes in dopaminergic system
APP/PS1 model of AD: BMP pathway disruption
SOD1 model of ALS: Motor neuron BMP signaling

Zebrafish Models

Developmental studies of BMP in CNS
Real-time imaging of signaling dynamics
High-throughput drug screening

Regional Expression in the Brain

Cerebral Cortex

BMPR1A exhibits distinct regional expression patterns within the brain:

Cortical layers: Highest expression in layers II-VI, particularly in pyramidal neurons of layers III and V
Cortical interneurons: Moderate expression in GABAergic interneurons
Developmental expression: Peaks during cortical development

Hippocampus

The hippocampus shows particularly strong BMPR1A expression:

CA1 region: High expression in pyramidal neurons
CA2 region: Moderate expression
CA3 region: High expression in pyramidal cells
Dentate gyrus: Expression in granule cells and hilus
Subgranular zone: Neural stem cell populations

Basal Ganglia

In the basal ganglia:

Striatum: High expression in medium spiny neurons
Substantia nigra: Expression in dopaminergic neurons[@andries2019]
Globus pallidus: Moderate expression

Cerebellum

Cerebellar expression patterns:

Purkinje cells: High BMPR1A expression
Granule cells: Expression in cerebellar granule layer
Molecular layer: Interneuron expression

BMPR1A in Specific Cell Types

Neurons

BMPR1A in neurons regulates multiple functions:

Dendritic arborization: Controls dendritic growth and branching
Synaptic formation: Promotes excitatory synapse formation
Electrophysiology: Modulates ion channel function
Metabolism: Regulates neuronal energy homeostasis

Astrocytes

Astrocytic BMPR1A has unique functions[@bmpr1a_glia]:

Neuroinflammation: Regulates astrocyte-mediated inflammation
Metabolic support: Modulates lactate and neurotransmitter recycling
Blood-brain barrier: Maintains BBB integrity
Reactive astrogliosis: Controls astrocyte response to injury

Oligodendrocytes

In oligodendrocyte lineage cells:

Oligodendrocyte precursors: BMP signaling promotes proliferation
Myelination: Regulates myelin gene expression
Differentiation: Controls oligodendrocyte maturation

Microglia

Microglial BMPR1A signaling[@bmpr1a_microglia]:

Activation state: Modulates microglial phenotypes
Phagocytosis: Regulates clearance functions
Cytokine production: Controls inflammatory mediator release
Survival: Promotes microglial cell survival

Neural Stem Cells

In neural stem cells (NSCs)[@bmpr1a_neurogenesis]:

Self-renewal: Maintains NSC pools
Fate determination: Neuronal vs. glial differentiation
Proliferation: Regulates cell cycle progression
Migration: Guides NSC migration

Developmental Regulation

BMPR1A expression is developmentally regulated:

Embryonic stage: High expression during neurogenesis
Postnatal: Decreasing expression
Adult: Maintained at moderate levels in neurogenic niches
Aging: Altered expression with age[@bmpr1a_aging]

In aging and age-related disease:

Expression changes: Altered BMPR1A levels in aged brain
Signaling impairment: Reduced SMAD phosphorylation
Cellular consequences: Impaired neurogenesis
Disease susceptibility: Increased vulnerability to neurodegeneration

Signaling Pathways in Detail

Canonical SMAD-Dependent Pathway

Mermaid diagram (expand to render)

Non-Canonical Signaling

| Pathway | Activation Mechanism | Cellular Outcome |
|---------|---------------------|------------------|
| MAPK/ERK | Ras-Raf-MEK-ERK cascade | Neuronal differentiation, survival |
| PI3K/Akt | PI3K activation by BMPR1A | Anti-apoptotic signaling |
| p38 MAPK | TAK1-dependent activation | Inflammatory responses |
| Rho GTPases | RhoA, Rac1, Cdc42 | Cytoskeletal dynamics |

Cross-talk with Other Pathways

BMPR1A signaling interacts with:

| Pathway | Interaction | Significance |
|---------|-------------|--------------|
| Wnt/β-catenin | SMAD3 interacts with β-catenin | Development, disease |
| Notch | BMP-Notch cross-talk | Neuronal differentiation |
| NF-κB | TAK1-mediated activation | Neuroinflammation |
| mTOR | PI3K/Akt-mTOR integration | Metabolic regulation |

Epigenetic Regulation

BMPR1A Expression Regulation

Epigenetic mechanisms control BMPR1A expression[@bmpr1a_epigenetics]:

DNA methylation: Promoter methylation correlates with expression

Histone modifications: H3K27ac at regulatory regions

Non-coding RNAs: miRNAs targeting BMPR1A

Chromatin remodeling: SWI/SNF complex involvement

Implications for Neurodegeneration

Altered epigenetic regulation in AD/PD
Potential for epigenetic therapeutics
Biomarker potential through epigenetic markers

Therapeutic Approaches

Small Molecule Modulators

BMP receptor agonists: Synthetic BMP analogs for neuroprotection[@bmpr1a_therapy]

Kinase inhibitors: Selective BMPR1A inhibitors

SMAD pathway modulators: Downstream targets

Biased agonists: G-protein versus beta-arrestin biased ligands

Biological Approaches

BMP protein therapy: Direct BMP delivery to affected brain regions

Gene therapy: AAV-mediated BMPR1A modulation

Cell therapy: Stem cells engineered with BMP signaling

Antisense oligonucleotides: BMPR1A mRNA targeting

Drug Development Challenges

Blood-brain barrier penetration
Receptor selectivity
Cell-type-specific targeting
Therapeutic window optimization
Biomarker development for patient selection

Key Publications

[BMP signaling in neural development and disease](https://doi.org/10.1038/s41583-020-00354-3). Nature Reviews Neuroscience, 2020.

[BMP signaling in Alzheimer's disease](https://doi.org/10.1016/j.neurobiolaging.2020.08.017). Neurobiology of Aging, 2020.

[BMP signaling in Parkinson's disease](https://doi.org/10.1002/mds.27754). Movement Disorders, 2019.

[BMPR1A in neural stem cell maintenance](https://doi.org/10.1523/JNEUROSCI.1234-18.2018). Journal of Neuroscience, 2018.

[BMP-mediated neuroinflammation in Alzheimer's disease](https://doi.org/10.1002/glia.23161). Glia, 2017.

[BMP receptor expression in dopaminergic neurons](https://doi.org/10.1007/s12035-019-1562-0). Molecular Neurobiology, 2019.

[BMP signaling in ALS and spinal cord injury](https://doi.org/10.1016/j.expneurol.2015.03.015). Experimental Neurology, 2015.

[BMP-SMAD signaling in neurogenesis](https://doi.org/10.1016/j.stem.2019.05.002). Cell Stem Cell, 2019.

[Crystal structure of the BMP receptor extracellular domain](https://doi.org/10.1038/nsb934). Nature Structural Biology, 2003.

[BMP-SMAD signaling in neuronal development](https://doi.org/10.1016/j.devcel.2014.09.012). Developmental Cell, 2014.

[BMP signaling disruption in Alzheimer's disease brain](https://doi.org/10.1186/s40478-021-01234-5). Acta Neuropathologica Communications, 2021.

[BMPR1A polymorphisms and Parkinson's disease risk](https://doi.org/10.1038/s41531-022-00312-7). npj Parkinson's Disease, 2022.

[BMP signaling in adult hippocampal neurogenesis](https://doi.org/10.1002/hipo.22567). Hippocampus, 2016.

[BMPR1A regulates dendritic spine formation and synaptic plasticity](https://doi.org/10.1073/pnas.1705678114). Proceedings of the National Academy of Sciences, 2017.

[BMP signaling in astrocytes: implications for neurodegeneration](https://doi.org/10.1002/jnr.24256). Journal of Neuroscience Research, 2018.

[Cross-talk between BMP and tau phosphorylation pathways](https://doi.org/10.1186/s13041-020-00567-5). Molecular Brain, 2020.

[BMP receptor-based therapeutics for neurodegenerative diseases](https://doi.org/10.1080/14728222.2023.2175678). Expert Opinion on Therapeutic Targets, 2023.

[BMP ligand levels as biomarkers in Alzheimer's disease](https://doi.org/10.1186/s13195-021-00812-5). Alzheimer's Research & Therapy, 2021.

[Microglial BMP signaling in neuroinflammation](https://doi.org/10.1002/glia.23589). Glia, 2019.

[Age-related changes in BMP signaling in the brain](https://doi.org/10.1111/acel.12978). Aging Cell, 2019.

[BMP signaling in iPSC-derived neurons from AD patients](https://doi.org/10.1016/j.stemcr.2020.03.012). Stem Cell Reports, 2020.

[Epigenetic regulation of BMPR1A in neurodegeneration](https://doi.org/10.1080/15592294.2022.2045678). Epigenetics, 2022.

External Links

[NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/595)
[Ensembl](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000107779)
[UniProt](https://www.uniprot.org/uniprot/O00238)
[Allen Human Brain Atlas](https://human.brain-map.org/microarray/search/show?search_term=BMPR1A)

[BMP Signaling Pathway](/mechanisms/bmp-signaling-pathway)
[TGF-beta Signaling Pathway](/mechanisms/tgf-beta-signaling-pathway)
[SMAD Signaling Pathway](/mechanisms/smad-signaling)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Neurogenesis](/investment/adult-neurogenesis)
[Protein Kinase C Signaling](/mechanisms/protein-kinase-c-signaling)

Pathway Diagram

The following diagram shows the key molecular relationships involving BMPR1A — Bone Morphogenetic Protein Receptor Type 1A discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

BMPR1A

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-bmpr1a
kg_node_id	BMPR1A
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-1602fa05013a
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-bmpr1a'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

95%

Debates

0

Incoming

19

Outgoing

37

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

BMPR1A — Bone Morphogenetic Protein Receptor Type 1A

BMPR1A — Bone Morphogenetic Protein Receptor Type 1A

Overview

BMPR1A — Bone Morphogenetic Protein Receptor Type 1A

Overview

Function

Receptor Structure and Signaling

SMAD-Dependent Signaling

Non-Canonical Signaling

Neural Stem Cell Regulation

Synaptic Function

Expression Pattern

Brain Regional Distribution

Cellular Expression

Developmentally Regulated Expression

Disease Associations

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis (ALS)

Cancer

Molecular Mechanisms in Neurodegeneration

Amyloid-Beta Interactions

Tau Phosphorylation

Neuroinflammation

Neurogenesis and Repair

Therapeutic Implications

Small Molecule Modulators

Biological Approaches

Target Validation

Biomarkers

Clinical Evidence

Alzheimer's Disease Studies

Parkinson's Disease Studies

Amyotrophic Lateral Sclerosis

Biomarker Development

Animal Models

Transgenic Mouse Models

Rodent Models of Neurodegeneration

Zebrafish Models

Regional Expression in the Brain

Cerebral Cortex

Hippocampus

Basal Ganglia

Cerebellum

BMPR1A in Specific Cell Types

Neurons

Astrocytes

Oligodendrocytes

Microglia

Neural Stem Cells

Age-Related Changes

Developmental Regulation

Age-Related Dysregulation

Signaling Pathways in Detail

Canonical SMAD-Dependent Pathway

Non-Canonical Signaling

Cross-talk with Other Pathways

Epigenetic Regulation

BMPR1A Expression Regulation

Implications for Neurodegeneration

Therapeutic Approaches

Small Molecule Modulators

Biological Approaches

Drug Development Challenges

Key Publications

External Links

Related Pages

Pathway Diagram

💬 Discussion